MediRama

Contact us LinkedIn

Resources

Offer updates on upcoming conferences and webinars focused on clinical trials, regulatory strategies, and oncology innovations.

Total 11

View More

[MediRama EDGE] A Review of Clinical Pharmacology Considerations in Antibody–Drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025.

  • 2026.01.29
View More

[MediRama EDGE] Redefining Bladder Cancer Therapy The Anktiva BLA Story.

  • 2025.04.24
View More

[MediRama EDGE] Evolution of CD19 CAR-T in B-ALL: Why AUCATZYL Stands Out?

  • 2025.03.27
View More

[MediRama EDGE] Zanidatamab's Groundbreaking Approval Story in HER2-Positive BTC

  • 2025.02.26
View More

[MediRama EDGE] Vyloy for Gastric Cancer

  • 2024.11.28
View More

[MediRama EDGE] NDA story of Rytelo(imetelstat)

  • 2024.10.24
View More

[MediRama EDGE] Tecelra BLA

  • 2024.09.26
View More

[MediRama EDGE] Belzutifan for RCC

  • 2024.08.29
View More

[MediRama EDGE] Imdelltra BLA story

  • 2024.07.25
View More

Significance of data quality getting regular approval from accelerated approval : Lumakras Case

  • 2024.04.25